CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 901 - 910 of 1130
Study Number Lead Group Study Title CIRB Study Status
ADVL18P1 COG An Open-Label Feasibility Study to Assess the Safety and Pharmacokinetics of Enasidenib in Pediatric Patients with Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML) with an Isocitrate Dehydrogenase-2 (IDH2) Mutation Pediatric CIRB Available to Open
ANBL09P1 COG A COG Pilot Study of Intensive Induction Chemotherapy and 131I-MIBG Followed by Myeloablative Busulfan/Melphalan (Bu/Mel) for Newly Diagnosed High-Risk Neuroblastoma: A Limited Institution Pilot Study Pediatric CIRB Available to Open
ASCT0631D COG A Comparison of Acute and Long-term Toxicities in Bone Marrow Donors with and without G-CSF Treatment Prior to Harvest: A Companion Study to ASCT0631 Pediatric CIRB Completed
ACNS1123 COG Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT): A Groupwide Phase II Study Pediatric CIRB Available to Open
ALTE07C1 COG Neuropsychological; Social; Emotional; and Behavioral Outcomes in Children with Cancer: A Groupwide Non-Therapeutic Study Pediatric CIRB Available to Open
ACCRN07 COG Protocol for the Enrollment on the Official COG Registry; The Childhood Cancer Research Network (CCRN) Pediatric CIRB Available to Open
ARST03P1 COG A Pilot Phase II Study for Children with Infantile Fibrosarcoma Pediatric CIRB Completed
PBTC-N14 PBTC CSF Cell-free Tumor DNA (CSF cfDNA) Liquid Biopsies for Pediatric, Adolescent, and Young Adult Patients with Primary Brain Tumors Pediatric CIRB Available to Open
AALL07P1 COG A Phase II Pilot Trial of Bortezomib (PS-341; Velcade; IND# 58;443) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL) Pediatric CIRB Completed
AOST1322 COG A Phase II Study of Eribulin (IND# 122686; NSC# 707389) in Recurrent or Refractory Osteosarcoma: An Intergroup NCTN Phase II Study Pediatric CIRB Completed
Displaying 901 - 910 of 1130